2026 ICD-10-CM Diagnosis Code F19.11Other psychoactive substance abuse, in remission

ICD-10-CM Codes›F01–F99›F10-F19›F19

ICD-10-CM F19.11
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

F19.11 is a billable ICD-10-CM diagnosis code for other psychoactive substance abuse, in remission. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 894 through 897. Coders also document this condition as harmful pattern of substance use in remission. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Mental and substance use disorders in remission.

Code Identity

ICD-10-CM Code
F19.11
Billable Status
Yes — Valid for Submission
Code Describes
Other psychoactive substance abuse, in remission
Short Description
Other psychoactive substance abuse, in remission
Same as the full description in the CMS dataset.
Parent Code
F19.1
Other psychoactive substance abuse

Code Classification

ChapterF01–F99Mental and behavioural disorders
SectionF10-F19Mental and behavioral disorders due to psychoactive substance use
CategoryF19Other psychoactive substance related disorders
This CodeF19.11Other psychoactive substance abuse, in remission

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Harmful pattern of substance use in remission
  • Harmful pattern of use of antidepressant
  • History of intravenous drug abuse
  • History of laxative abuse
  • Nondependent harmful pattern of mixed substance use
  • Nondependent harmful pattern of mixed substance use in remission
  • Nondependent harmful pattern of use of antidepressant in remission

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Other (or unknown) substance use disorder, mild, in early remission
  • Other (or unknown) substance use disorder, mild, in sustained remission

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Abuse
      • drug NEC (non-dependent)
        • in remission (early) (sustained)

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MBD026
Mental and substance use disorders in remission
Default principal diagnosis: inpatient Yes · outpatient Yes

Convert F19.11 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
305.83 Antidepress abuse-remiss
Approximate The match is approximate rather than exact.
ICD-9-CM
305.93 Drug abuse NEC-in remiss
Approximate The match is approximate rather than exact.

Code History & ChangesHistory

Replacement F19.11 replaces the following previously assigned code(s):

  • F19.10 - Other psychoactive substance abuse, uncomplicated
FY 2018AddedAdded to the ICD-10-CM code setEffective October 1, 2017.
FY 2019–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About F19.11Overview

Is F19.11 (Other psychoactive substance abuse) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other psychoactive substance abuse, in remission on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does F19.11 group to?

When other psychoactive substance abuse, in remission is the principal diagnosis on an inpatient stay, it groups to MS-DRG 894, 895, 896, 897, with relative weights from 0.6169 to 1.7451 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of F19.11?

Under the General Equivalence Mappings, other psychoactive substance abuse, in remission converts to ICD-9-CM 305.83 (antidepress abuse-remiss) and 305.93 (drug abuse NEC-in remiss). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.